Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Junji Hirate is active.

Publication


Featured researches published by Junji Hirate.


International Journal of Pharmaceutics | 1990

Disposition of warfarin in analbuminemic rats

Junji Hirate; Chunyan Zhu; Isamu Horikoshi; Sumi Nagase

The disposition characteristics of warfarin were studied in analbuminemic rats after intravenous bolus injection of 1 and 40 mg/kg of drug to investigate the effects of plasma protein binding on drug disposition. With both doses of warfarin, total body warfarin clearance (CL) was markedly faster and its apparent volume of distribution (Vdβ) significantly greater in the analbuminemic rats in comparison to controls. Further, the apparent elimination rate constant (β) was significantly greater and the corresponding elimination half-life (t12β) shorter in the rats with low plasma albumin. Whole body autoradiograms demonstrated that the distribution of warfarin to the liver, skeletal muscle and brain was greater in the analbuminemic rats which was in good agreement with the larger Vdβ observed in this group of rats. The results suggested that the disposition characteristics of warfarin were markedly altered in the rats with low plasma albumin concentrations due to reduced plasma warfarin protein binding.


Journal of Pharmacy and Pharmacology | 1989

Enhancement of phenytoin binding to tissues in rats by heat treatment.

Yoshiteru Kato; Junji Hirate; Kazuo Sakaguchi; Isamu Horikoshi

Abstract— Phenytoin binding to heat‐treated tissue homogenates has been examined to characterize the phenytoin binding to tissues. The binding to the heat‐treated tissue homogenates was enhanced in all tissues studied compared with controls. The heating might produce the changes in conformation of proteins in tissues and then enhance phenytoin binding to tissue homogenates.


Yakugaku Zasshi-journal of The Pharmaceutical Society of Japan | 1991

First-Pass Metabolism of Acetoaminophen in Thyroxine Treated Rats

Chunyan Zhu; Junji Hirate; Ikuo Kanamoto; Teruaki Nakagawa; Isao Adachi; Isamu Horikoshi; Vijay O. Bhargava

The study on the first-pass metabolism of acetaminophen was carried out in normal and thyroxine-treated rats, administered 30 mg/kg by three routes of intravenous, intraperitoneal, and oral one. Unconjugated acetaminophen and two major metabolites, glucuronide and sulfate in the plasma and urine were then measured 5 and 24 h after the administration, respectively. It was found that there was no difference in total percentage of excreted amount, independent of the routes for administration, between normal and thyroxine-treated rats. This fact shows that acetaminophen is absorbed completely from the gastrointestinal tract. However, it was also found that the extraction ratio of gastrointestinal tract in thyroxine-treated rats became smaller, and that the volume of distribution and total body clearance became larger than those in normal rats. The first-pass metabolism of acetaminophen was found to be influenced by the continuous administration of thyroxine.


Japanese Journal of Hospital Pharmacy | 1985

Determination of lower level of serum phenytoin by Emit method.

Ikuo Kanamoto; Yasuji Ishizuka; Kiyonobu Yoshimatsu; Junji Hirate; Isamu Horikoshi

Determination of lower level of serum phenytoin (PHT) was made by homogeneous enzyme immunoassay (Emit) in the following methods:(A) Wide range calibration method, (B) Extrapolated calibration method, and (C) Mixed sample method. In the method A and B, calibration curves of serum PHT levels were generated using a nonlinear least-squares regression program (EMITFIT) with a microcomputer. It was concluded that method A was most reliable of the three. In method A, the PHT recoveries in spiked serum samples in the concentrations of 0.25, 0.5, 1.0 μg/ml were 104.6, 102.6, 100.1%, and coefficients of variation were 11.4, 6.8, 2.3%, respectively.


Biopharmaceutics & Drug Disposition | 1990

First-pass metabolism of acetaminophen in rats after low and high doses

Junji Hirate; Chunyan Zhu; Isamu Horikoshi; Vijay O. Bhargava


Journal of pharmacobio-dynamics | 1986

Disposition of glycyrrhetic acid and its glycosides in healthy subjects and patients with pseudoaldosteronism.

Katsutoshi Terasawa; Miyuki Bandoh; Hiroyori Tosa; Junji Hirate


Biopharmaceutics & Drug Disposition | 1989

Further observations on the disposition characteristics of salicylic acid in analbuminemic rats

Junji Hirate; Yoshiteru Kato; Isamu Horikoshi; Sumi Nagase; Clarence T. Ueda


Journal of pharmacobio-dynamics | 1984

SALIVARY EXCRETION OF UREA IN DOGS

Jun Watanabe; Satoshi Mizuno; Naoki Masuda; Yayoi Hayashi; Kikuo Iwamoto; Junji Hirate; Shoji Ozeki


Journal of pharmacobio-dynamics | 1987

AGE-DEPENDENT CHANGES IN PHENYTOIN TISSUE BINDINGS IN RATS : COMPARISON BETWEEN IN VIVO AND IN VITRO TISSUE-TO-BLOOD PARTITION COEFFICIENTS (Kp VALUES) OF PHENYTOIN

Yoshiteru Kato; Junji Hirate; Kazuo Sakaguchi; Masaharu Ueno; Isamu Horikoshi


Biopharmaceutics & Drug Disposition | 1990

Disposition of phenytoin in analbuminemic rats

Junji Hirate; Isamu Horikoshi; Sumi Nagase

Collaboration


Dive into the Junji Hirate's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Shoji Ozeki

Nagoya City University

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Vijay O. Bhargava

University of Nebraska Medical Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Clarence T. Ueda

University of Nebraska Medical Center

View shared research outputs
Researchain Logo
Decentralizing Knowledge